Amgen Announces Results From Phase 3 PAVES Study Evaluating...

FOLFOX and FOLFIRI are two of the most commonly used chemotherapy regimens for colorectal cancer.

http://www.biospace.com/news_story.aspx?StoryID=285853&full=1